Effects of Five-Year Treatment with Testosterone Undecanoate on Metabolic and Hormonal Parameters in Ageing Men with Metabolic Syndrome

Moderate Weight Loss Is Sufficient to Affect Thyroid Hormone Homeostasis and Inhibit Its Peripheral Conversion

(2014) Ritesh V. Agnihothri et al.   THYROID

Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1

(2013) Se Won Kim et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study)

(2013) G. Hackett et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study

(2013) A. M. Traish et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Testicular function and bone metabolism—beyond testosterone

(2013) Alberto Ferlin et al.   Nature Reviews Endocrinology

Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss

(2013) Farid Saad et al.   Obesity

Effects of 5-Year Treatment With Testosterone Undecanoate on Lower Urinary Tract Symptoms in Obese Men With Hypogonadism and Metabolic Syndrome

(2013) Davide Francomano et al.   UROLOGY

Trunk Fat Negatively Influences Skeletal and Testicular Functions in Obese Men: Clinical Implications for the Aging Male

(2013) Silvia Migliaccio et al.   International Journal of Endocrinology

Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study

(2012) Antonio Aversa et al.   Aging Male

Effect of Testosterone Supplementation With and Without a Dual 5α-Reductase Inhibitor on Fat-Free Mass in Men With Suppressed Testosterone Production

(2012) Shalender Bhasin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Body Mass Index Regulates Hypogonadism‐Associated CV Risk: Results from a Cohort of Subjects with Erectile Dysfunction

(2011) Giovanni Corona et al.   Journal of Sexual Medicine

Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study

(2010) Svetlana Y. Kalinchenko et al.   CLINICAL ENDOCRINOLOGY

Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men

(2010) Frederick C.W. Wu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome

(2009) G. Corona et al.   Aging Male